Tag: investment
-
AI-Designed Antibodies for Start-Up Sought in Open Call
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company.
-
European Life Science Venture Fund Raises €472M
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe.
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
Infographic – Cruising Biotech Index Takes Late Dip
NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Seed Stage Investors Raise $450M for New Fund
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Infographic – Few Venture Dollars for Women Founders
Despite an increase in venture investment dollars so far this year, investments in new companies started by women continue to lag behind.
-
Off-the-Shelf Stem Cell Company Forms, Gains $72M
A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds.
-
Gene Therapy Delivery Company Gains $26M in Early Funds
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round.